These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21365783)

  • 21. Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients.
    Motomiya Y; Ando Y; Haraoka K; Sun X; Iwamoto H; Uchimura T; Maruyama I
    Kidney Int; 2003 Dec; 64(6):2244-52. PubMed ID: 14633149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiol compounds inhibit the formation of amyloid fibrils by beta 2-microglobulin at neutral pH.
    Yamamoto K; Yagi H; Ozawa D; Sasahara K; Naiki H; Goto Y
    J Mol Biol; 2008 Feb; 376(1):258-68. PubMed ID: 18155723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dialysis-related amyloidosis: late finding or hidden epidemic?
    Dember LM; Jaber BL
    Semin Dial; 2006; 19(2):105-9. PubMed ID: 16551286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialysis-related amyloidosis and clinical significance of extracorporeal removal of beta2-microglobulin.
    Gejyo F; Suzuki S; Arakawa M
    Ther Apher; 1997 May; 1(2):126-8. PubMed ID: 10225756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary beta2-microglobulin analysis in chronic kidney disease and hemodialyzed patients.
    Michelis R; Sela S; Ben-Zvi I; Nagler RM
    Blood Purif; 2007; 25(5-6):505-9. PubMed ID: 18187941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration.
    Leypoldt JK
    Semin Dial; 2005; 18(5):401-8. PubMed ID: 16191181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril.
    Ivanova MI; Sawaya MR; Gingery M; Attinger A; Eisenberg D
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10584-9. PubMed ID: 15249659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible heat-induced dissociation of β2-microglobulin amyloid fibrils.
    Kardos J; Micsonai A; Pál-Gábor H; Petrik É; Gráf L; Kovács J; Lee YH; Naiki H; Goto Y
    Biochemistry; 2011 Apr; 50(15):3211-20. PubMed ID: 21388222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-terminal unfolding of an amyloidogenic β2-microglobulin fragment: ΔN6β2-microglobulin.
    Motomiya Y; Higashimoto Y; Uji Y; Suenaga G; Ando Y
    Amyloid; 2015 Mar; 22(1):54-60. PubMed ID: 25523495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single disulfide bond differentiates aggregation pathways of beta2-microglobulin.
    Chen Y; Dokholyan NV
    J Mol Biol; 2005 Nov; 354(2):473-82. PubMed ID: 16242719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the C-terminal 28 residues of beta2-microglobulin in amyloid fibril formation.
    Ivanova MI; Gingery M; Whitson LJ; Eisenberg D
    Biochemistry; 2003 Nov; 42(46):13536-40. PubMed ID: 14622000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis.
    Kazama JJ; Maruyama H; Gejyo F
    Nephrol Dial Transplant; 2001; 16 Suppl 4():31-5. PubMed ID: 11402095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of beta2-microglobulin clearance on the risk factors of cardiovascular disease in hemodialysis patients.
    Kuragano T; Kida A; Furuta M; Nanami M; Otaki Y; Hasuike Y; Nonoguchi H; Nakanishi T
    ASAIO J; 2010; 56(4):326-32. PubMed ID: 20431482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible mechanisms of polyphosphate-induced amyloid fibril formation of β
    Zhang CM; Yamaguchi K; So M; Sasahara K; Ito T; Yamamoto S; Narita I; Kardos J; Naiki H; Goto Y
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12833-12838. PubMed ID: 31182591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific glycosaminoglycans promote unseeded amyloid formation from beta2-microglobulin under physiological conditions.
    Borysik AJ; Morten IJ; Radford SE; Hewitt EW
    Kidney Int; 2007 Jul; 72(2):174-81. PubMed ID: 17495865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Core and heterogeneity of beta2-microglobulin amyloid fibrils as revealed by H/D exchange.
    Yamaguchi K; Katou H; Hoshino M; Hasegawa K; Naiki H; Goto Y
    J Mol Biol; 2004 Apr; 338(3):559-71. PubMed ID: 15081813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column.
    Gejyo F; Kawaguchi Y; Hara S; Nakazawa R; Azuma N; Ogawa H; Koda Y; Suzuki M; Kaneda H; Kishimoto H; Oda M; Ei K; Miyazaki R; Maruyama H; Arakawa M; Hara M
    Artif Organs; 2004 Apr; 28(4):371-80. PubMed ID: 15084199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The beta2-microglobulin/cystatin C ratio--a potential marker of post-transplant lymphoproliferative disease.
    Bökenkamp A; Grabensee A; Stoffel-Wagner B; Hasan C; Henne T; Offner G; Lentze MJ
    Clin Nephrol; 2002 Dec; 58(6):417-22. PubMed ID: 12508963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
    Miyata T
    Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodialysis-related amyloidosis: Is it still relevant?
    Kaneko S; Yamagata K
    Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.